Research Site 62 — Phoenix, Arizona

Public research footprint of Research Site 62, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Chronic Obstructive Pulmonary Disease (COPD) · Atherosclerotic Cardiovascular Disease (ASCVD) · Secondary Progressive Multiple Sclerosis (SPMS) · Metastatic Castration-Resistant Prostate Cancer

Recently updated registry entries

NCT05039840 — Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus… (Active Not Recruiting)
NCT06872892 — The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With… (Recruiting)
NCT05878769 — A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Research Site 62?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.